Amos Adler M.Sc. President & Co-Founder [email protected] Twitter: @memotext IMPROVING THE BOTTOM LINE FOR HEALTHCARE BY INCREASING MEDICATION COMPLIANCE. TRUSTED INNOVATIONS IN PATIENT ADHERENCE
Memotext Patient Adherence - Innovation for Canadian Association of Healthcare Reimbursement
Dec 02, 2014
Case study in patient adherence, medication compliance and discussion of innovation in health IT and behavior change / behavior economics engine. Presented to the Canadian Association for Healthcare Reimbursement. Discussion of methodology for patient adherence, change management framework for introduction digital health innovations.
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Amos Adler M.Sc.President & Co-Founder
[email protected]: @memotext
IMPROVING THE BOTTOM LINE FOR HEALTHCARE BY INCREASING MEDICATION COMPLIANCE.
TRUSTED INNOVATIONS IN PATIENT ADHERENCE
2
MEMOTEXT®
Evidence-based, ROI-driven digital adherence and behaviour change solutions.
We improve the bottom line for healthcare stakeholders by increasing adherence to treatment.
Integrate the innovation via:
• Clinical Workflow• Via Health Plan• @ Pharmacy• Direct-to-consumer
The MEMOTEXT® Intervention
Powering validated principles:
Population, Condition, Medication-Class, Brand Specific Personalization
The MEMOTEXT® Intervention
Personalization
Contact Us To learn More
5
Automated, Personalized, Interactive, Self-Referencing Information, Motivation + Live Support
Personalized Content by Text and Mobile
Automating behavioral economics to changing attitudes, beliefs and circumstances of each patient over time.
- Biometrics- EMR Data- Claims Data- Patient
Responses
@memotext
Case Study: T2 Diabetes
Pharmacy Recruitment Intervention Results/references
• In-store• DTC• Call Center• (Web + POS)
Self-efficacy & depression adherence METFORMIN. Adaptive SMS and IVR outreach and interactive education program.
Very significant increases in MPR – 18+ months
79% of patients rate programs very highly
17% + change in patients rating confidence in self management
76% of patient self-report feeling better, healthier and happier since starting a T2 Diabetes program
Select MEMOTEXT Pharma and other Use Cases
Recruitment, Intervention, MeasurementPrivacy, Pharmacovigilance, Info Security
8
MEMOTEXTLabs
Collaborative development to automate and assess digital evidence-based behavior change.
Leverage and grow behavioral economics & artificial intelligence engine.
Development of an agile science methodology.
1. US Veterans Affairs, Univ. of Pittsburgh: CHF Follow-Up.2. Arizona State Univ. TEXT2Cope: SMS: CBT + self talk3. Nova S.E Univ.: Resolving Med Issues in Diabetes (SMS)4. St. Michael’s Hospital: Prenatal Vaccination Adherence
Related Documents
